1932

Abstract

Clinical and biological features of patients with the idiopathic hypereosinophilic syndrome (HES) are heterogeneous. Recent evidence suggests at least two distinct underlying hematological disorders involving myeloid and lymphoid cells, respectively. We therefore suggest that the term idiopathic should be abandoned in the classification of HES. This review defines the “myeloproliferative” and “lymphocytic” variants of the HES and addresses the management of each variant, focusing on diagnosis and treatment of the newly identified lymphocytic variant.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.54.101601.152431
2003-02-01
2024-06-25
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.med.54.101601.152431
Loading
/content/journals/10.1146/annurev.med.54.101601.152431
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error